Obama’s War on American Generals

Daniel Greenfield, a Shillman Journalism Fellow at the Freedom Center, is a New York writer focusing on radical Islam. He is completing a book on the international challenges America faces in the 21st century.


Firing a few good men.

Petraeus’ Fall and Benghazigate — on The Glazov Gang

Jamie Glazov is Frontpage Magazine's editor. He holds a Ph.D. in History with a specialty in Russian, U.S. and Canadian foreign policy. He is the author of the critically acclaimed and best-selling, United in Hate: The Left’s Romance with Tyranny and Terror. His new book is High Noon For America. He is the host of Frontpage’s television show, The Glazov Gang, and he can be reached at jamieglazov11@gmail.com. Visit his site at JamieGlazov.com.


Unravelling the strange details — and connections — of a sex scandal and a terrorist attack.

Petraeus Recants Obama’s Benghazi Fiction

Matthew Vadum is an award-winning investigative reporter and the author of the book, "Subversion Inc.: How Obama’s ACORN Red Shirts Are Still Terrorizing and Ripping Off American Taxpayers."


With nothing to lose, the general comes clean.

Consequences of the Petraeus Scandal

Alan W. Dowd writes on defense and security.


The political and — geopolitical — ramifications.

Petraeus Scandal Means Media Can No Longer Ignore Benghazi

Rick Esenberg is president and general counsel of the Wisconsin Institute for Law & Liberty and an adjunct professor at Marquette University Law School. The opinions expressed here are his own.


The general will eventually testify — and the fallout will be magnified because of his resignation.

Gen. Petraeus treated for prostate cancer – AP

Mary Belle Snow lives in Montecito California

Oct 6, 9:01 AM EDT
Gen. Petraeus treated for prostate cancer
WASHINGTON (AP) — Gen. David Petraeus, the top U.S. commander for the wars in Iraq and Afghanistan, was diagnosed with prostate cancer in February and has since undergone two months of radiation treatment.
Petraeus, 56, was diagnosed with early-stage prostate cancer, which [...]